Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-25 @ 9:54 PM
NCT ID: NCT01188551
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01188551
Study Brief: Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dexmedetomidine w/o Midazolam Dexmedetomidine given intranasally in OR without any pre-medication. None None 0 25 0 25 View
Fentanyl w/o Midazolam Fentanyl given intranasally in the OR without any pre-medication. None None 0 25 0 25 View
Fentanyl w/ Midazolam Midazolam given orally pre-op and fentanyl given intranasally in OR. None None 0 25 0 25 View
Dexmedetomidine w/ Midazolam Midazolam given orally pre-op and dexmedetomidine given intranasally in OR. None None 0 25 0 25 View
Serious Events(If Any):
Other Events(If Any):